Anti-inflammatory drugs often cause diverse side effects and have high lipophilicity, therefore there is a need to search for new anti-inflammatory agents or new drug delivery systems (NDDS) that improve their characteristics. Thus,…

The eye is susceptible to various diseases commonly difficult to treat. To overcome the barriers imposed by this organ for required drugs penetration, technological strategies have been implemented to ocular formulations. Among them are the…

The aim of the present study was to develop a topical liposomal formulation as a transdermal delivery of rivastigmine for the treatment of Alzheimer disease as an alternative to the oral dosage form and to achieve smooth continuous drug…

Join experts from the pharmaceutical industry for a free 3-day webcast series. Each day a specific pharma-related topic will be discussed, and the audience will have the opportunity to ask questions directly to the experts. Each session has…

Present work investigates the possibility of a polyethyleneglycolylated (PEGylated) microemulsion (ME) to deliver drug to the posterior segment of eye. Triamcinolone acetonide (TA), a widely used drug in intraocular diseases, was selected…

Recent advances in the development of nanocarriers have started a new era in Formulation Science. Among various nanoparticles, solid lipid nanoparticles (SLNs) offer an attractive carrier system to conventional colloidal carriers, such as…

The objective of the study was to assess the effect of enhanced mucoadhesion of a cationic mucoadhesive nanostructured lipid carrier (NLC) on its ocular disposition after topical administration. The NLC was made mucoadhesive by surface…

Article By Dr. Catherine Sheehan - Senior Director of Science – Excipients at the United States Pharmacopeial Convention With significant innovations in pharmaceuticals, including biologic drugs and treatments for rare diseases, the need…

See the presentation of Sophie Hughes from Gattefossé at CPhI Worldwide where she talked through a poster presentation on the formulating of cannabinoids with lipid excipients. To find out more about this and Gattefossé´s whole portfolio of…